Literature DB >> 10753711

The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging.

J Zhang1, G P Leser, A Pekosz, R A Lamb.   

Abstract

Deletion of the cytoplasmic tails of the influenza A virus spike glycoproteins, hemagglutinin (HA) and neuraminidase (NA), has previously been shown to result in markedly defective virion morphogenesis (Jin et al., 1997, EMBO J. 16, 1236-1247). We have found that influenza A virus preparations lacking the HA and NA cytoplasmic tails (HAt-/NAt-) have a reduced vRNA to protein content, contain an increase in cellular RNA contaminants, and exhibit increased resistance to ultraviolet (UV) inactivation. There is also a direct correlation between abnormal virion morphology and reduced infectivity. The data suggest that the HAt-/NAt- virion population contains a broader range of number of packaged RNA segments than wild-type (wt) virus. Sucrose gradient centrifugation analysis indicated the presence of a subpopulation of virions with pronounced deformation in virion morphology and reduced infectivity. The role of the HA and NA cytoplasmic tails was examined further by using a trans-complementation assay and it was found that expression of wt HA and NA from cDNAs followed by HAt-/NAt- virus infection caused the formation of a pseudotype virus with wt sedimentation properties. Taken together the data indicate that the HA and NA cytoplasmic tails affect not only virion morphology but also proper genome packaging. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753711     DOI: 10.1006/viro.2000.0228

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding.

Authors:  Benjamin J Chen; George P Leser; David Jackson; Robert A Lamb
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

3.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

4.  Requirements for budding of paramyxovirus simian virus 5 virus-like particles.

Authors:  Anthony P Schmitt; George P Leser; David L Waning; Robert A Lamb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.

Authors:  J Zhang; A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal.

Authors:  Rosalia Mora; Enrique Rodriguez-Boulan; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.

Authors:  Masaki Imai; Kazunori Kawasaki; Takato Odagiri
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.

Authors:  Benjamin J Chen; George P Leser; Eiji Morita; Robert A Lamb
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions.

Authors:  Sarah L Noton; Elizabeth Medcalf; Dawn Fisher; Anne E Mullin; Debra Elton; Paul Digard
Journal:  J Gen Virol       Date:  2007-08       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.